Viktor Fleming

2.5k total citations · 3 hit papers
10 papers, 1.8k citations indexed

About

Viktor Fleming is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Viktor Fleming has authored 10 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Viktor Fleming's work include Immune cells in cancer (7 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Viktor Fleming is often cited by papers focused on Immune cells in cancer (7 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Viktor Fleming collaborates with scholars based in Germany, Austria and Israel. Viktor Fleming's co-authors include Peter Altevogt, Jochen Utikal, Rebekka Weber, Xiaoying Hu, Christopher Groth, Viktor Umansky, Vasyl S. Nagibin, Viktor Umansky, Christoffer Gebhardt and C Blattner and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Viktor Fleming

10 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

2018 614 citations Christopher Groth, Xiaoying Hu et al. British Journal of Cancer profile →
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

2018 406 citations Rebekka Weber, Viktor Fleming et al. Frontiers in Immunology profile →
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

2018 355 citations Viktor Fleming, Xiaoying Hu et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viktor Fleming Germany	9	1.3k	938	459	179	163	10	1.8k
Evgenii N. Tcyganov United States	6	1.5k 1.1×	947 1.0×	509 1.1×	239 1.3×	159 1.0×	7	2.0k
Christopher Groth Germany	14	1.5k 1.1×	1.1k 1.2×	584 1.3×	240 1.3×	187 1.1×	18	2.1k
Alexandra Sevko Germany	19	1.4k 1.1×	1.1k 1.2×	712 1.6×	241 1.3×	126 0.8×	22	2.1k
Swetha Anandhan United States	9	899 0.7×	951 1.0×	612 1.3×	202 1.1×	209 1.3×	13	1.8k
Rebekka Weber Germany	15	1.6k 1.2×	1.2k 1.2×	620 1.4×	240 1.3×	190 1.2×	16	2.2k
Maxim Markovic United States	6	1.2k 0.9×	482 0.5×	558 1.2×	154 0.9×	109 0.7×	7	1.6k
Joel Crespo United States	7	863 0.7×	674 0.7×	396 0.9×	183 1.0×	149 0.9×	8	1.4k
Pratik Bhojnagarwala United States	12	955 0.7×	587 0.6×	283 0.6×	96 0.5×	163 1.0×	23	1.3k
Yueyun Pan China	4	801 0.6×	508 0.5×	600 1.3×	260 1.5×	212 1.3×	5	1.4k
Hugo Arasanz Spain	20	940 0.7×	1.3k 1.3×	354 0.8×	140 0.8×	251 1.5×	57	1.8k

Countries citing papers authored by Viktor Fleming

Since Specialization

Citations

This map shows the geographic impact of Viktor Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Fleming more than expected).

Fields of papers citing papers by Viktor Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Fleming. The network helps show where Viktor Fleming may publish in the future.

Co-authorship network of co-authors of Viktor Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Fleming. A scholar is included among the top collaborators of Viktor Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Fleming. Viktor Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Fleming, Viktor, Xiaoying Hu, Rebekka Weber, et al.. (2019). Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling. Cancer Research. 79(18). 4715–4728. 110 indexed citations

2.

Blattner, C, Viktor Fleming, Rebekka Weber, et al.. (2018). CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions. Cancer Research. 78(1). 157–167. 151 indexed citations

3.

Fleming, Viktor, Xiaoying Hu, Rebekka Weber, et al.. (2018). Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression. Frontiers in Immunology. 9. 398–398. 355 indexed citations breakdown →

4.

Groth, Christopher, Xiaoying Hu, Rebekka Weber, et al.. (2018). Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. British Journal of Cancer. 120(1). 16–25. 614 indexed citations breakdown →

5.

Weber, Rebekka, Viktor Fleming, Xiaoying Hu, et al.. (2018). Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors. Frontiers in Immunology. 9. 1310–1310. 406 indexed citations breakdown →

6.

Sammar, Marei, Monika Siwetz, Hamutal Meiri, et al.. (2016). Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface. Histochemistry and Cell Biology. 147(5). 565–574. 41 indexed citations

7.

Umansky, Viktor, C Blattner, Viktor Fleming, et al.. (2016). Myeloid-derived suppressor cells and tumor escape from immune surveillance. Seminars in Immunopathology. 39(3). 295–305. 64 indexed citations

8.

Ortner, Daniela, Christoph H. Tripp, Viktor Fleming, et al.. (2015). Impaired gp100-Specific CD8+ T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model. Journal of Investigative Dermatology. 135(11). 2785–2793. 18 indexed citations

9.

McGarry, Conor K., V.P. Cosgrove, Viktor Fleming, Joe M. O’Sullivan, & Alan R. Hounsell. (2009). An analysis of geometric uncertainty calculations for prostate radiotherapy in clinical practice. British Journal of Radiology. 82(974). 140–147. 6 indexed citations

10.

Jarritt, Peter H., Alan R. Hounsell, K.J. Carson, et al.. (2005). Use of combined PET/CT images for radiotherapy planning: initial experiences in lung cancer. British Journal of Radiology. Supplement_28(1). 33–40. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact